Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1 results about "Leflunomide" patented technology

This medication is used to treat rheumatoid arthritis, a condition in which the body's defense system (immune system) fails to recognize the body as itself and attacks the healthy tissues around the joints.

Chinese-western medicine pharmaceutical composition containing extract of six-rehmannia and its application in preparing medicine for treating liver cancer

ActiveCN117462621BLiu Wei Di HuangWestern medicine
The application discloses a Chinese-western medicine pharmaceutical composition containing Liuwei Dihuang extract and application thereof in preparation of a medicine for treating liver cancer. The pharmaceutical composition comprises leflunomide and Liuwei Dihuang extract, and the Liuwei Dihuang extract is Liuwei Dihuang pill water extract or Liuwei Dihuang pill alcohol extract. In the pharmaceutical composition, the leflunomide and the Liuwei Dihuang extract can be mixed together to form a single administration unit, or can be independent administration units and used respectively. The application compares the administration of leflunomide alone, leflunomide combined with Liuwei Dihuang water extract, leflunomide combined with Liuwei Dihuang alcohol extract, Liuwei Dihuang water extract alone and Liuwei Dihuang alcohol extract alone. The results of animal experiments and cell experiments show that the Liuwei Dihuang alcohol extract has a significant effect of promoting the treatment of liver cancer by leflunomide. The application can be converted to clinic, and provides a possibility of reducing the dosage of leflunomide for clinical medication, which is helpful for the treatment of liver cancer.
Owner:JIAXING UNIV